Fig. 4From: The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesityCorrelations between plasma levels of intestinal fatty-acid binding protein (I-FABP) and host metabolic and inflammatory parameters. Data of all experimental groups were gathered and analyzed using two-tailed Pearson’s correlation testBack to article page